Skip to content

Panelmanagement for medically unexplained physical symptoms

Proactive and integrated care for patients at risk for persistent medically unexplained physical symptoms (MUPS): population care and panel management in primary care

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27854
Enrollment
195
Registered
2013-09-13
Start date
2014-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In English: (persistent) medically unexplained physical symptoms (MUPS) In Dutch: (chronische) somatisch onverklaarde lichamelijke klachten (SOLK)

Interventions

Every three months, patients at risk will be empanelled and reported back with the panel management dashboard to GPs in the intervention group. The dashboard also gives information about relevant heal

Sponsors

Coöperatie VGZ UA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult (18-65) patients at risk for persistent MUPS will be identified and empanelled by analysis of their extracted EMRs with a validated selection method that has been developed with data mining techniques.

Exclusion criteria

Exclusion criteria: current or previous malignancies in the last 5 years, current or previous pregnancy in the last year and also some chronic neurological conditions

Design outcomes

Primary

MeasureTime frame
The proportion of the patients at risk for persistent MUPS that are referred for a mental health care intervention, which stands for embarking on a (secondary) psychosocial intervention track annex to the somatic track.

Secondary

MeasureTime frame
Overall contact frequency, total number and number of distinct ICPC codes suggestive of MUPS (appendix B), number of referrals to somatic care, number of prescribed medicines (special notation of antidepressants, benzodiazepines and pain medication), number of additional examinations, 4-DSQ subscale and total scores and panel (group) size and -change.

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)